IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q1 2017 Holdings

Filed 2017-04-28 | 10 holdings | $15.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anika Therapeutics Inc(ANIK)COM035255108$7.9M181,57350.4%
Charles RIV Labs Intl Inc(CRL)COM159864107$7.7M85,61249.2%
Aetna Inc NewCOM00817Y108$11.4K89,0000.1%
Amerisourcebergen Corp(COR)COM03073E105$11.2K126,0000.1%
Gilead Sciences Inc(GILD)COM375558103$7.9K117,0000.1%
Mckesson Corp(MCK)COM58155Q103$7.6K51,0000.0%
Osiris Therapeutics Inc NewCOM68827R108$5.5K1,140,2220.0%
GNC Hldgs IncCOM CL A36191G107$3.1K422,9550.0%
Achillion Pharmaceuticals in(ACHNEUR)COM00448Q201$2.1K497,8070.0%
Immucell Corp(ICCC)COM PAR $0.10452525306$931168,3230.0%